• Leptin (116-130), Amide, Mouse for Metabolic Research

  2026-09-16

  Leptin (116-130), amide, mouse is a 15-residue peptide fragment supplied for research on energy homeostasis, obesity, diabetes, and leptin signaling. Its reported solubility and storage specifications support controlled preparation, while native leptin literature provides biological context rather than proof that this fragment reproduces every full-length hormone effect.

• Q-VD-OPh for Apoptosis and Cell Survival

  2026-09-16

  Q-VD-OPh is a cell-permeable pan-caspase inhibitor for separating caspase-driven death from downstream survival, recovery, and metastatic phenotypes. This practical guide connects apoptosis research, cryopreservation workflows, and disease modeling with assay design and troubleshooting guidance.

• Myriocin Restores dAGE Metabolic Homeostasis

  2026-09-15

  A 2025 Nutrients study shows that myriocin counteracts high dietary advanced glycation end product exposure in male mice by coordinating hepatic lipid and glucose regulation with AMPK–PGC1α-driven mitochondrial activation. The findings connect sphingolipid synthesis inhibition with reduced adiposity, improved metabolic biomarkers, adipose thermogenesis, and broad metabolic reprogramming, while remaining limited to a preclinical model.

• Zosuquidar (LY335979): A Smarter MDR Playbook

  2026-09-15

  Zosuquidar (LY335979) offers translational researchers a focused way to interrogate P-glycoprotein-driven multidrug resistance. This thought-leadership article connects transporter mechanism, functional rescue assays, disease-state pharmacokinetics, and clinical strategy while defining where the evidence is strong—and where it should not be overextended.

• Partial BACE Inhibition and Synaptic Transmission

  2026-09-14

  Satir et al. tested whether moderate BACE inhibition could lower amyloid-β production without disrupting neuronal communication. Their data indicate that reductions of less than 50% in secreted Aβ were compatible with preserved synaptic transmission in primary rat cortical cultures, whereas stronger inhibition reduced both measures.

• EdU Imaging Kits (HF594) and the PNI Decision Point

  2026-09-14

  A mechanistic and translational guide to using EdU-based S-phase measurements to interpret Schwann-cell dedifferentiation, tumor–nerve crosstalk, and therapeutic response in pancreatic ductal adenocarcinoma.

• FAK Inhibitor 14: From Mechanism to Translation

  2026-09-13

  A translational perspective on using FAK Inhibitor 14 to interrogate the PARP1/FAK/COL5A1 axis, EMT, migration, and cholesterol-adapted ovarian cancer models while maintaining rigorous experimental boundaries.

• Sildenafil Citrate: A Proteoform-Aware Assay Guide

  2026-09-12

  Sildenafil Citrate is a cGMP-specific phosphodiesterase type 5 inhibitor with broad value in vascular signaling research. This guide translates native proteoform findings into practical assay design, selectivity controls, and interpretable cGMP and ERK readouts.

• α-Linolenic Acid Research Workflows

  2026-09-11

  Build reproducible ALA experiments spanning lipid flux, cardiovascular phenotypes, inflammation, and cancer biology. This practical guide combines solvent handling, time-course design, pathway-aware controls, and a cautious translation of new arachidonic acid immune findings.

• Developmental SSRI Exposure and Mu Opioid Signaling

  2026-09-11

  Cambre’s 2026 Columbia University dissertation shows that developmental exposure to selective serotonin reuptake inhibitors produces persistent, motivation-specific reward deficits in adolescent and adult mice. Progressive-ratio performance improved after mu opioid receptor antagonism or nucleus accumbens MOR knockdown, whereas further SSRI treatment and the MOR agonist tianeptine were ineffective, pointing to a dissociation between serotonergic history and opioid control of effortful behavior.

• Capsazepine: From TRPV1 Blockade to Translation

  2026-09-10

  A translational strategy for using Capsazepine to separate TRPV1 biology from calcium-current, TRPM8, nociceptive, and exploratory apoptosis effects while improving mechanistic confidence in pain models.

• Cabazitaxel (XRP6258): Resistant Model Guide

  2026-09-10

  Cabazitaxel (XRP6258, SKU B2157) is a semi-synthetic taxane derivative for studying microtubule dynamics disruption and antiproliferative responses, including P-glycoprotein-expressing and taxane-resistant cancer cell models. It is intended for controlled DMSO- or ethanol-based workflows, not water-only assays, and prepared solutions should be used promptly rather than stored long term.

• N-MYC–eIF4G1 Axis in inv(16) AML

  2026-09-09

  Peramangalam and colleagues identify an N-MYC enhancer and the translation-initiation factor eIF4G1 as a survival pathway in inv(16) acute myeloid leukemia. Their integrated use of transcriptomic analysis, leukemia models, enhancer studies, and functional perturbation supports the N-MYC/eIF4G1 axis as a mechanistic framework for studying leukemic maintenance, while also defining important limits for therapeutic interpretation.

• Fenipentol Workflows for Secretion Research

  2026-09-09

  Fenipentol provides a defined small-molecule tool for testing pancreatic, hepatobiliary, and intestinal secretion phenotypes rather than relying only on complex Chuanxiong extracts. This guide connects historical secretion data with modern metabolomics, ESR1-oriented hypotheses, practical dosing workflows, and troubleshooting strategies.

• Upd2 Directs Disciplined Tracheal Stem Cell Migration

  2026-09-08

  Dong et al. show that the Drosophila fat body controls the anterior-to-posterior migration of tracheal progenitors through the cytokine Upd2 and tracheal JAK/STAT signaling. The study connects inter-organ cytokine transport, planar cell polarity, and vesicular trafficking to the maintenance of coordinated stem cell movement.

8475 records 1/565 page Next 12345 下5页 Last page